Sign Out
Pregnancy: There is insufficient experience with Vildagliptin in pregnant women. Vildagliptin was not teratogenic in either rats or rabbits. The fetal risk for humans is unknown. Vildagliptin should not be used during pregnancy unless the benefit to the mother outweighs the potential risk to the fetus.
Breast-feeding: It is unknown whether Vildagliptin is excreted in human milk. Animal studies have shown excretion of Vildagliptin in milk. Vildagliptin should not be administered to breast-feeding woman.
Continue with Google